Literature DB >> 24799721

Urinary Tract Infections: Leading Initiatives in Selecting Empiric Outpatient Treatment (UTILISE).

Eric Landry1, Linda Sulz2, Ali Bell3, Lane Rathgeber4, Heather Balogh5.   

Abstract

BACKGROUND: Overuse of fluoroquinolone antibiotics is associated with outbreaks of methicillin-resistant Staphylococcus aureus and of Clostridium difficile-associated diarrhea and increasing resistance in gram-negative organisms. Over the past decade, resistance of Escherichia coli to ciprofloxacin has increased in the Regina Qu'Appelle Health Region. In August 2011, an exploratory audit of the Regina General Hospital (RGH) emergency department showed that 20% of new antibiotic orders were for fluoroquinolones, and 60% of these new fluoroquinolone orders were for ciprofloxacin. It was postulated that ciprofloxacin was predominantly prescribed for outpatients with urinary tract infection.
OBJECTIVE: To develop, implement, and evaluate a best-practice algorithm for the empiric treatment of uncomplicated urinary tract infection in the RGH emergency department, as part of an educational initiative for emergency physicians.
METHODS: A literature review was conducted and local antibiogram data were analyzed to establish a best-practice algorithm for treatment of uncomplicated urinary tract infection in outpatients seen in the emergency department. A chart review was conducted from January to March 2011 to establish a baseline of empiric antibiotic use. An educational strategy targeting emergency physicians described changes in antibiotic resistance patterns in the health region, principles of antimicrobial stewardship, drivers of resistance, and the results of a literature review of best practice for urinary tract infection in outpatients. A post-intervention audit was conducted from January to March 2012 to determine changes in practice.
RESULTS: Comparison of results from the post-intervention audit with baseline data showed that adherence to best practice increased significantly, from 41% (39/96) before the intervention to 66% (50/76) after the intervention (odds ratio [OR] 2.81, 95% confidence interval [CI] 1.51-5.25; p < 0.001). There was also a significant change in overall antibiotic selection (OR 0.25, 95% CI 0.11-0.58; p < 0.001). Further analysis suggested that this significant change was driven by a decrease in use of ciprofloxacin, from 32% (31/96) to 11% (8/76).
CONCLUSION: Creation of a best-practice algorithm and education focused on emergency physicians significantly increased adherence to best practice and optimized antibiotic prescribing for outpatients with uncomplicated urinary tract infection by limiting overuse of fluoroquinolones, primarily ciprofloxacin.

Entities:  

Keywords:  Escherichia coli resistance; emergency department; empiric treatment; fluoroquinolones; urinary tract infection

Year:  2014        PMID: 24799721      PMCID: PMC4006756          DOI: 10.4212/cjhp.v67i2.1339

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  17 in total

1.  Practice spotlight: pharmacists in an antimicrobial stewardship program.

Authors:  Linda Dresser; Sandra Nelson
Journal:  Can J Hosp Pharm       Date:  2010-07

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.

Authors:  James A Karlowsky; Daryl J Hoban; Melanie R Decorby; Nancy M Laing; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse.

Authors:  Annie Wong-Beringer; Lee H Nguyen; Michelle Lee; Kimberly A Shriner; Jean Pallares
Journal:  Pharmacotherapy       Date:  2009-06       Impact factor: 4.705

Review 5.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 6.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors:  D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

7.  Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.

Authors:  Donald I Hsu; Mark P Okamoto; Rekha Murthy; Annie Wong-Beringer
Journal:  J Antimicrob Chemother       Date:  2005-02-22       Impact factor: 5.790

8.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

Authors:  Marcus J Zervos; Ellie Hershberger; David P Nicolau; David J Ritchie; Lori K Blackner; Elizabeth A Coyle; Andrew J Donnelly; Stephen F Eckel; Robert H K Eng; Alexandra Hiltz; Arpi G Kuyumjian; William Krebs; Angee McDaniel; Patricia Hogan; Teresa J Lubowski
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

9.  Trimethoprim/sulfamethoxazole resistance in urinary tract infections.

Authors:  Ozlem Guneysel; Ozge Onur; Mustafa Erdede; Arzu Denizbasi
Journal:  J Emerg Med       Date:  2008-03-06       Impact factor: 1.484

10.  Fluoroquinolone use and Clostridium difficile-associated diarrhea.

Authors:  Margaret E McCusker; Anthony D Harris; Eli Perencevich; Mary-Claire Roghmann
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  4 in total

1.  Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes.

Authors:  Sarah C J Jorgensen; Samantha L Yeung; Mira Zurayk; Jill Terry; Maureen Dunn; Paul Nieberg; Jean Pallares; Annie Wong-Beringer
Journal:  Open Forum Infect Dis       Date:  2018-05-02       Impact factor: 3.835

Review 2.  BundlED Up: A Narrative Review of Antimicrobial Stewardship Initiatives and Bundles in the Emergency Department.

Authors:  Maressa Santarossa; Emily N Kilber; Eric Wenzler; Fritzie S Albarillo; Ethan J Sterk
Journal:  Pharmacy (Basel)       Date:  2019-11-01

3.  Antimicrobial Stewardship in the Emergency Department.

Authors:  Trang D Trinh; Kenneth P Klinker
Journal:  Infect Dis Ther       Date:  2015-09-11

4.  Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative.

Authors:  Kevin Lin; Yorgo Zahlanie; Jessica K Ortwine; Norman S Mang; Wenjing Wei; L Steven Brown; Bonnie C Prokesch
Journal:  Open Forum Infect Dis       Date:  2020-05-21       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.